{"_links": {"parentPackage": {"href": "/mdr/ct/packages/sdtmct-2021-06-25", "title": "SDTM Controlled Terminology Package 46 Effective 2021-06-25", "type": "Terminology"}, "rootItem": {"href": "/mdr/root/ct/sdtmct/codelists/C120525", "title": "Version-agnostic anchor resource for codelist C120525", "type": "Root Value Domain"}, "self": {"href": "/mdr/ct/packages/sdtmct-2021-06-25/codelists/C120525", "title": "CDISC SDTM Immunogenicity Specimen Assessments Test Code Terminology", "type": "Code List"}}, "conceptId": "C120525", "definition": "Terminology relevant to the immunogenicity specimen test codes of the CDISC Study Data Tabulation Model.", "extensible": "true", "name": "Immunogenicity Specimen Assessments Test Code", "preferredTerm": "CDISC SDTM Immunogenicity Specimen Assessments Test Code Terminology", "submissionValue": "ISTESTCD", "synonyms": ["Immunogenicity Specimen Assessments Test Code"], "terms": [{"conceptId": "C147272", "definition": "A measurement of the binding antidrug antibody in a biological specimen. A binding antidrug antibody is an antibody that binds to a test article, and/or portion(s) of the test article.", "preferredTerm": "Binding Antidrug Antibody Measurement", "submissionValue": "ADA_BAB", "synonyms": ["Binding Antidrug Antibody"]}, {"conceptId": "C147273", "definition": "A measurement of the neutralizing binding antidrug antibody in a biological specimen. A neutralizing binding antidrug antibody is a type of ADA that binds to the functional portion of a test article leading to diminished or negated pharmacological activity.", "preferredTerm": "Neutralizing Binding Antidrug Antibody Measurement", "submissionValue": "ADA_NAB", "synonyms": ["Neutralizing Binding Antidrug Antibody"]}, {"conceptId": "C147274", "definition": "A measurement of the neutralizing cross-reactive binding antidrug antibody in a biological specimen. A neutralizing cross-reactive binding antidrug antibody is a type of ADA that binds to an endogenous molecule that is structurally similar to an analogue test article and diminishes or negates its function.", "preferredTerm": "Neutralizing Cross-Reacting Binding Antidrug Antibody Measurement", "submissionValue": "ADA_NX", "synonyms": ["Neutraliz Cross-React Bind Antidrug AB", "Neutralizing Cross-Reactive Binding Antidrug Antibody"]}, {"conceptId": "C147275", "definition": "A measurement of the cross-reactive binding antidrug antibody in a biological specimen. A cross-reactive binding antidrug antibody is a type of ADA that binds to the endogenous molecule that is structurally similar to an analogue test article.", "preferredTerm": "Cross-Reactive Binding Antidrug Antibody Measurement", "submissionValue": "ADA_X", "synonyms": ["Cross-Reactive Binding Antidrug Antibody"]}, {"conceptId": "C132360", "definition": "A measurement of the Ebola virus specific IgG antibody secreting cells in a biological specimen.", "preferredTerm": "Ebola Virus Specific IgG Antibody Secreting Cell Count", "submissionValue": "EVIGGASC", "synonyms": ["EBOV Specific IgG AB Secreting Cells"]}, {"conceptId": "C132361", "definition": "A measurement of the Ebola virus specific IgM antibody secreting cells in a biological specimen.", "preferredTerm": "Ebola Virus Specific IgM Antibody Secreting Cell Count", "submissionValue": "EVIGMASC", "synonyms": ["EBOV Specific IgM AB Secreting Cells"]}, {"conceptId": "C120622", "definition": "A measurement of the H1 specific IgG antibody secreting cells in a biological specimen.", "preferredTerm": "Influenza Hemagglutinin 1 Specific IgG Antibody Secreting Cell Count", "submissionValue": "H1IGGASC", "synonyms": ["H1 Specific IgG ASCs", "H1 Specific IgG Antibody Secreting Cells"]}, {"conceptId": "C120623", "definition": "A measurement of the H3 specific IgG antibody secreting cells in a biological specimen.", "preferredTerm": "Influenza Hemagglutinin 3 Specific IgG Antibody Secreting Cell Count", "submissionValue": "H3IGGASC", "synonyms": ["H3 Specific IgG ASCs", "H3 Specific IgG Antibody Secreting Cells"]}, {"conceptId": "C158217", "definition": "A measurement of the HIV-1 seroreactivity in a biological specimen.", "preferredTerm": "HIV-1 Seroreactivity Measurement", "submissionValue": "HIV1SR", "synonyms": ["HIV-1 Seroreactivity"]}, {"conceptId": "C158216", "definition": "A measurement of the HIV-2 seroreactivity in a biological specimen.", "preferredTerm": "HIV-2 Seroreactivity Measurement", "submissionValue": "HIV2SR", "synonyms": ["HIV-2 Seroreactivity"]}, {"conceptId": "C132362", "definition": "A measurement of the total IgM antibody secreting cells in a biological specimen.", "preferredTerm": "IgM Antibody Secreting Cell Count", "submissionValue": "IGMABSC", "synonyms": ["IgM Antibody Secreting Cells"]}, {"conceptId": "C120624", "definition": "A measurement of the total IgG antibody secreting cells in a biological specimen.", "preferredTerm": "Total IgG Antibody Secreting Cell Count", "submissionValue": "TIGGASC", "synonyms": ["Total IgG ASCs", "Total IgG Antibody Secreting Cells"]}, {"conceptId": "C161337", "definition": "A relative measurement (ratio or percentage) of T-lymphocyte proliferation due to stimulation by an antigen of interest to a non-stimulated T-lymphocyte proliferation control.", "preferredTerm": "T-Lymphocyte Proliferation Index", "submissionValue": "TLYMPIDX", "synonyms": ["T-Lymphocyte Proliferation Index"]}]}